Page last updated: 2024-12-05

ethylenediamine-n,n'-bis(2-hydroxyphenylacetic acid)

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

ethylenediamine-N,N'-bis(2-hydroxyphenylacetic acid): synthetic iron chelator; RN given refers to parent cpd; structure in 3rd source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID14432
CHEMBL ID21178
SCHEMBL ID144838
MeSH IDM0058400

Synonyms (45)

Synonym
4-14-00-02099 (beilstein handbook reference)
ec 214-625-3
benzeneacetic acid, .alpha.,.alpha.'-(1,2-ethanediyldiimino)bis[2-hydroxy-
n,n'-ethylenebis(2-(o-hydroxyphenyl)glycine)
edhpa
ethylenediamine-n,n'-bis((2-hydroxyphenyl)acetic acid)
ethylenediamine-n,n'-bis(2-hydroxyphenylacetic acid)
ethylenediamine-di(o-hydroxyphenyl)acetic acid
benzeneacetic acid, alpha,alpha'-(1,2-ethanediyldiimino)bis(2-hydroxy-
benzeneacetic acid, alpha,alpha'-(1,2-ethanediylimino)bis(2-hydroxy-
einecs 214-625-3
chel 138
edbpha
brn 2679807
eddha ,
ethylenediamine-di(2-hydroxyphenyl)acetic acid
glycine, n,n'-ethylenebis(2-(o-hydroxyphenyl)-
c18h20n2o6
edbhpa
CHEMBL21178
1170-02-1
2,2'-(ethane-1,2-diylbis(azanediyl))bis(2-(2-hydroxyphenyl)acetic acid)
AKOS016003633
benzeneacetic acid, alpha,alpha'-(1,2-ethanediyldiimino)bis(2-hydroxy-, iron(3+) salt
6021-71-2
ferric n,n'-ethylenebis-2-(o-hydroxyphenyl)glycinate
FT-0626305
SCHEMBL144838
2-[2-[[carboxy-(2-hydroxyphenyl)methyl]amino]ethylamino]-2-(2-hydroxyphenyl)acetic acid
W-108574
n,n'-ethylenebis(2-[2-hydroxyphenyl]glycine)
[(2-([carboxy(2-hydroxyphenyl)methyl]amino)ethyl)amino](2-hydroxyphenyl)acetic acid #
ethylenediamine-di(o-hydroxyphenylacetic acid)
2,2'-(ethane-1,2-diylbis(azanediyl))bis(2-(2-hydroxyphenyl)aceticacid)
labotest-bblt00452997
DTXSID30864677
ethylenediaminebis(o-hydroxyphenylacetic acid)
Q5322836
mfcd00004247
DS-16475
O10548
A928658
2,2'-(ethane-1,2-diylbis(azanediyl))-bis(2-(2-hydroxyphenyl)acetic acid)
CS-0137208
n,n'-ethylenebis-(o-hydroxyphenylglycine)

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"Because of a projected pilot study with EDHPA in Cooley's anemia patients, animal studies with emphasis on reversibility of potential toxic signs were performed."( Preliminary toxicity findings in dogs and rodents given the iron chelator ethylenediamine-N,N'-bis(2-hydroxyphenylacetic acid) (EDHPA).
Fleischman, RW; Metterville, JJ; Rosenkrantz, H, 1986
)
0.5

Bioavailability

ExcerptReferenceRelevance
", regarding their bioavailability or potential pro-oxidant activity."( Reduction of paraquat-induced renal cytotoxicity by manganese and copper complexes of EGTA and EHPG.
Chatterjee, PK; Gard, PR; Hague, T; Naughton, DP; Samai, M, 2008
)
0.35
"Naturally occurring and synthetic chelating ligands can act as suppressants for fungal pathogens, nematodes and weeds, based on their ability to alter micronutrient bioavailability in soil, particularly iron."( Extraction of metals from mildly acidic tropical soils: Interactions between chelating ligand, pH and soil type.
Hocking, RK; Nelson, PN; Orr, R; Pattison, A, 2020
)
0.56
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID186662Percent change in iron levels was determined in urine using iron overload rat model where the route of administration is Peroral1986Journal of medicinal chemistry, Jul, Volume: 29, Issue:7
Esters and lactones of phenolic amino carboxylic acids: prodrugs for iron chelation.
AID186658Percent change in iron levels was determined in feces using iron overload rat model where the route of administration is Peroral1986Journal of medicinal chemistry, Jul, Volume: 29, Issue:7
Esters and lactones of phenolic amino carboxylic acids: prodrugs for iron chelation.
AID186656Percent change in iron levels was determined in feces using iron overload rat model where the route of administration is Intraperitoneal1986Journal of medicinal chemistry, Jul, Volume: 29, Issue:7
Esters and lactones of phenolic amino carboxylic acids: prodrugs for iron chelation.
AID186660Percent change in iron levels was determined in urine using iron overload rat model where the route of administration is Intraperitoneal1986Journal of medicinal chemistry, Jul, Volume: 29, Issue:7
Esters and lactones of phenolic amino carboxylic acids: prodrugs for iron chelation.
AID184621Compound was evaluated for lethal dose after intraperitoneal administration using iron overload rat model1986Journal of medicinal chemistry, Jul, Volume: 29, Issue:7
Esters and lactones of phenolic amino carboxylic acids: prodrugs for iron chelation.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (86)

TimeframeStudies, This Drug (%)All Drugs %
pre-199024 (27.91)18.7374
1990's11 (12.79)18.2507
2000's38 (44.19)29.6817
2010's10 (11.63)24.3611
2020's3 (3.49)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.09

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.09 (24.57)
Research Supply Index4.50 (2.92)
Research Growth Index4.59 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.09)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (3.37%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other86 (96.63%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]